LOS ANGELES, CALIFORNIA -- (October 25, 2018) Exact Imaging (www.exactimaging.com), the world’s leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance for the prostate, announced that Skyline Urology, one of Southern California’s largest private urology practices, will acquire the ExactVu™ micro-ultrasound system for real-time targeted prostate biopsies in California.

“At Skyline Urology, we are dedicated to providing the highest level of patient care, and investments in the newest imaging technologies to allow our physicians to achieve these outcomes is essential”, says Dr. Richard D. David, Skyline Urology’s Chief Medical Officer.  “Our acquisition of this ExactVu high resolution micro-ultrasound system will allow our urologists to actually visualize suspicious regions, and then target their prostate biopsies in real-time. Skyline patients will benefit from this excellent new platform that will allow us to ultimately improve our biopsies with the end goal of allowing our physicians to more accurately diagnose significant prostate cancer”.

Dr. David adds “The ExactVu micro-ultrasound system is a paradigm shift in real-time imaging striving to get even more accurate biopsies using the highest resolution modalities to enable the fastest, most detailed imaging of the prostate. With the system’s FusionVu™ feature, we can also align the patient’s prostate MRI with the live micro-ultrasound image to either perform Cognitive Assist™ or micro-ultrasound/MRI fusion-guided biopsies, all with the benefit of the 70-micron resolution of micro-ultrasound. This allows us to see lesions that were unseen with our older technologies.”

“We are thrilled to have Skyline Urology as the first practice in California to adopt our ExactVu micro-ultrasound platform,” says Randy AuCoin, Exact Imaging’s President and CEO. “The ExactVu micro-ultrasound system provides the highest real-time resolution for targeted prostate biopsies and through this progressive urology practice, patients in California can now have access to micro-ultrasound for their prostate biopsies”.

The ExactVu customer base is growing globally as the urological community is recognizing the power of micro-ultrasound to provide excellent resolution for visualizing the prostate and providing real-time targeted guidance of prostate biopsies in a manner that is fast, cost-effective, and convenient for the patient.

About Skyline Urology:

Skyline Urology (formerly Urology Specialists of Southern California) is the largest group of urology specialists in the Los Angeles Area with a mission to deliver evidence-based, patient-centered, state-of-the-art urological care. It provides a complete range of urological medical services including an in-house Lab, a Cancer Center of Excellence, and a Physician Dispensing Program. Currently, Skyline Urology operates in various areas throughout Southern California, from the San Fernando Valley to the South Bay.  They have multiple locations to better serve patients nearby where they live and work. Over 50,000 patients are seen annually with over 150,000 visits in the last year.

About Exact Imaging

Exact Imaging (www.exactimaging.com) is the world’s leader in high-resolution micro-ultrasound systems enabling real-time imaging and guided biopsies in the urological market for prostate cancer. Exact Imaging’s ExactVu™ micro-ultrasound platform operates at 29 MHz and enables a whole new level of resolution with the benefits of ease of use, affordability, and is an extension of the current urological workflow. Using the Exact Imaging platform, urologists are able to visualize areas of interest in the prostate and specifically target biopsies at those areas. For the minority of cases where MRI might assist (i.e., prior negative biopsies), the FusionVu™ micro-US/MRI fusion application operates on the ExactVu micro-ultrasound platform and facilitates MRI fusion-based targeting. The ExactVu micro-ultrasound system and FusionVu have received regulatory approval in the European Union (CE Mark), the United States (FDA 510(k)) and Canada (Health Canada medical device license).